Arena Pharmaceuticals Inc
ARNA
ARNA was delisted on the 10th of March, 2022.
1 hedge funds and large institutions have $0 invested in Arena Pharmaceuticals Inc in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 312 closing their positions.
100% less funds holding
Funds holding: 316 → 1 (-315)
100% less funds holding in top 10
Funds holding in top 10: 7 → 0 (-7)
100% less capital invested
Capital invested by funds: $4.86B → $0 (-$4.86B)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 312
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$530M |
| 2 |
BlackRock
New York
|
-$452M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$361M |
| 4 |
State Street
Boston,
Massachusetts
|
-$213M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$167M |
ARNA Hedge Fund Activity: Q1 2022 in Review
1 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q1 2022, worth a combined $0 — down 100% from $4.86B a quarter earlier.
Sellers outnumbered buyers: 312 funds closed out of ARNA and 0 opened new positions — a net loss of 312 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Vanguard Group, exiting entirely with an estimated $530M sold.
- 1 institutional investor held Arena Pharmaceuticals Inc (ARNA) as of Q1 2022, down from 316 in Q4 2021.
- Funds reported $0 of Arena Pharmaceuticals Inc stock for Q1 2022, down 100% quarter-over-quarter.
- 0 funds opened new Arena Pharmaceuticals Inc positions in Q1 2022 and 312 closed out, a net change of -312 holders.
- The largest Arena Pharmaceuticals Inc seller in Q1 2022 was Vanguard Group, an estimated $530M sold.
Based on aggregated 13F filings for Q1 2022.